225 related articles for article (PubMed ID: 6614643)
1. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.
Peto R; Speizer FE; Cochrane AL; Moore F; Fletcher CM; Tinker CM; Higgins IT; Gray RG; Richards SM; Gilliland J; Norman-Smith B
Am Rev Respir Dis; 1983 Sep; 128(3):491-500. PubMed ID: 6614643
[TBL] [Abstract][Full Text] [Related]
2. Relevance of airflow obstruction and mucus hypersecretion to mortality.
Wiles FJ; Hnizdo E
Respir Med; 1991 Jan; 85(1):27-35. PubMed ID: 2014356
[TBL] [Abstract][Full Text] [Related]
3. The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men.
Vestbo J; Knudsen KM; Rasmussen FV
Respir Med; 1989 May; 83(3):207-11. PubMed ID: 2595038
[TBL] [Abstract][Full Text] [Related]
4. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Thorax; 1990 Aug; 45(8):579-85. PubMed ID: 2402719
[TBL] [Abstract][Full Text] [Related]
5. Chronic mucus hypersecretion in COPD and death from pulmonary infection.
Prescott E; Lange P; Vestbo J
Eur Respir J; 1995 Aug; 8(8):1333-8. PubMed ID: 7489800
[TBL] [Abstract][Full Text] [Related]
6. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
Vestbo J; Prescott E; Lange P
Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
[TBL] [Abstract][Full Text] [Related]
7. [Chronic expectoration and risk of death in chronic obstructive lung disease].
Prescott EI; Lange P; Vestbo J
Ugeskr Laeger; 1996 Nov; 158(45):6456-60. PubMed ID: 8992683
[TBL] [Abstract][Full Text] [Related]
8. Mucus hypersecretion in chronic obstructive pulmonary disease.
Rogers DF
Novartis Found Symp; 2001; 234():65-77; discussion 77-83. PubMed ID: 11199104
[TBL] [Abstract][Full Text] [Related]
9. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
Del Donno M; Olivieri D
Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
[TBL] [Abstract][Full Text] [Related]
10. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Am Rev Respir Dis; 1990 Mar; 141(3):613-7. PubMed ID: 2310094
[TBL] [Abstract][Full Text] [Related]
11. [Expectoration--an underestimated symptom?].
Vestbo J; Lange P
Ugeskr Laeger; 1993 Sep; 155(39):3100-3. PubMed ID: 8212397
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.
Liu Z; Geng W; Jiang C; Zhao S; Liu Y; Zhang Y; Qin S; Li C; Zhang X; Si Y
Exp Biol Med (Maywood); 2017 Sep; 242(15):1534-1541. PubMed ID: 28795606
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
14. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men.
Annesi I; Kauffmann F
Am Rev Respir Dis; 1986 Oct; 134(4):688-93. PubMed ID: 3767125
[TBL] [Abstract][Full Text] [Related]
15. Mucus hypersecretion, airways obstruction, and mortality from chronic lung disease.
Lancet; 1984 Feb; 1(8372):320. PubMed ID: 6141385
[No Abstract] [Full Text] [Related]
16. Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD.
Carter R; Nicotra B; Huber G
Chest; 1994 Dec; 106(6):1730-9. PubMed ID: 7988192
[TBL] [Abstract][Full Text] [Related]
17. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
Maestrelli P; Saetta M; Mapp CE; Fabbri LM
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
[TBL] [Abstract][Full Text] [Related]
18. Vital prognosis after hospitalization for COPD: a study of a random population sample.
Vestbo J; Prescott E; Lange P; Schnohr P; Jensen G
Respir Med; 1998 May; 92(5):772-6. PubMed ID: 9713639
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease.
Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
Acta Pharmacol Sin; 2007 Aug; 28(8):1166-74. PubMed ID: 17640479
[TBL] [Abstract][Full Text] [Related]
20. Regional mucus transport following unproductive cough and forced expiration technique in patients with airways obstruction.
Hasani A; Pavia D; Agnew JE; Clarke SW
Chest; 1994 May; 105(5):1420-5. PubMed ID: 8181329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
